Rosuvastatin Calcium

Tsanangudzo Pfupi

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP
Rosuvastatin Calcium Hypercholesterolemia Mumba/CEP 20705 CEP2015-240


Product Detail

Product Tags

PRODUCT DETAIL

瑞舒伐他汀钙 Rosuvastatin Calcium 147098-20-2 Mumba/CEP
RSM(Crystal) 147118-40-9 Mumba
RSM(Crude) 147118-40-9 Mumba
RSP - Mumba
RS-8 147118-36-3 Mumba
RS-8-1 147118-37-4 Mumba
TP-8 131466-61-0 Mumba
TP-11 147118-35-2 Mumba
TP-13 147118-39-6 Mumba
RS-10 289042-12-2 Mumba
RS-11 355806-00-7 Mumba

Tsanangudzo

Rosuvastatin Calcium (BANM, JAN, USAN) inozivikanwa seRosuvastatin muUS.uye inokwikwidza HMG-CoA reductase inhibitor ine IC50 ye11 nM[1].Rosuvastatin Calcium inovhara zvine simba ether-a-go-go gene gene (hERG) ikozvino ine IC50 ye195 nM, inonoke cardiac repolarization, uye nekudaro inorebesa chiitiko chinogona kuita durations (APDs) uye kugadzirisa QT interval (QTc) nguva[2].Rosuvastatin Calcium inoderedza kutaura kwehERG yakakura uye kupindirana kwekupisa kweprotein 70 (Hsp70) nehERG protein.Rosuvastatin Calcium inoshanda zvikuru mukuderedza yakaderera-density lipoprotein (LDL) cholesterol, triglycerides, uye C-reactive protein mazinga[3].

Rumwe ruzivo pamusoro pezvibvumirano zvekupa mazita ezvinodhaka: International Nonproprietary Names.

Chiziviso Chakakosha: Iyo Drugs.com yepasi rose dhatabhesi iri mukuburitswa kweBETA.Izvi zvinoreva kuti ichiri kugadzirwa uye inogona kunge iine zvisizvo.Izvo hazvina kuitirwa sechinotsiva hunyanzvi uye kutonga kwachiremba wako, wezvemishonga kana imwe nyanzvi yehutano.Hazvifanirwi kutorwa kuratidza kuti kushandiswa kwemishonga chero ipi zvayo munyika ipi zvayo yakachengeteka, yakakodzera kana inoshanda kwauri.Bvunza nyanzvi yako yezvehutano usati watora chero mushonga.

MuUS, Rosuvastatin (rosuvastatin systemic) inhengo yeboka rezvinodhaka statins uye inoshandiswa kurapa Atherosclerosis, High Cholesterol, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Yakakwira LDL, Hyperlipopro IIb - Yakakwira LDL VLDL, Hyperlipoproteinemia Rudzi rwechitatu - Yakasimudzwa beta-VLDL IDL, Hyperlipoproteinemia Rudzi IV - Yakakwirisa VLDL, Hypertriglyceridemia uye Kudzivirira kweMwoyo weMwoyo Chirwere.

Background

Inosarudza, inokwikwidza inhibitor yeHMG-CoA reductase, iyo zvakare antilipemic.

 

Storage

Upfu

-20°C

3 years

4°C

2 years
In solvent

-80°C

6 mwedzi

-20°C

1 mwedzi

Chimiro chemakemikari

Rosuvastatin Calcium

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

HUNHU MANAGEMENT

Quality management1

Proposal18Quality Consistency Evaluation mapurojekiti akatenderwa4,uye6mapurojekiti ari pasi pekubvumidzwa.

Quality management2

Yepamberi yepasirese yemhando manejimendi system yakaisa hwaro hwakasimba hwekutengesa.

Quality management3

Kutariswa kwemhando yepamusoro kunofamba kuburikidza nehupenyu hwese kutenderera kwechigadzirwa kuti ive nechokwadi chemhando nekurapa.

Quality management4

Professional Regulatory Affairs timu inotsigira zvinodiwa zvemhando panguva yekushandisa uye kunyoreswa.

KUTUNGAMIRIRA KWEKUGARA

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cpf14-1

DCS Control Room

PARTNER

Kudyidzana kwenyika dzose
International cooperation
Kushandira pamwe kwemumba
Domestic cooperation

  • Zvakapfuura:
  • Zvinotevera:

  • Nyora meseji yako pano uye utumire kwatiri

    Zvigadzirwa zvikamu